See the exhibition La première est jamais bonne ! and the publication Savoir/Faire: la multiplication des possibles from the Savoir / Faire project.


The Savoir / Faire project offers artists a research/creation residency program in the field of printmaking. The project is designed in the spirit of collaborative mentoring, involving 2 artists from the Saguenay-Lac-Saint-Jean region and 2 artists from Quebec City and Val-David.

The Savoir / Faire project is developed with the close involvement of two artistic and financial partners who are recognized artist-run centers in the field of printmaking: L'Atelier de l'Île in Val-David and the Engramme center in Quebec City.

For the first phase of the project, the selected artists are : Ilana Pichon (member of center Engramme), Marilyse Goulet (member of L'Atelier de l'Île) and two local artists, Magali Baribeau-Marchand and Émili Dufour.

These four artists will participate in a joint research/creation residency in September 2024 in the newly renovated printmaking studios at Centre SAGAMIE. The residency will culminate in a group exhibition at Centre SAGAMIE an opening reception scheduled for September 26, 2024, to present the results of their experiments to the public.

The two Saguenay-Lac-Saint-Jean artists will then complete a residency at the partner artist-run center that selected them. Émili Dufour will be in residence at Engramme, and Magali Baribeau-Marchand at L'Atelier de l'Île.

Other related activities will be added to this wonderful program. For example, artist Julie Bellavance , who specializes in lithography, will be in residence at Centre SAGAMIE March 2024 to create new works while contributing her expertise to the relaunch of our workshop. Other artists in residence and specialized training programs will be announced at a later date.

The Savoir / Faire project is made possible thanks to financial support from the Programme de partenariat territorial du Saguenay-Lac-Saint-Jean, a partnership agreement between CALQ, the City of Alma and the region's MRCs.